During a severe allergic reaction (anaphylaxis), children who received epinephrine before arriving at the hospital are less ...

Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...

The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...

Researchers confirmed that black-legged ticks (Ixodes scapularis) can trigger alpha-gal syndrome in humans. A 10-year ...

Bridge the gap between uncertainty and action with insights into symptoms that warrant immediate medical attention.

Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...

Type I allergy, an IgE antibody triggered hypersensitivity disease, represents a common public health problem affecting about one third of the world´s population. Upon exposure to allergens, IgE ...

A recent study found First Nations Australians were twice as likely to present to an emergency department with asthma or ...

For Hanna Newnham, 27, her one time McDonald's favourites are now completely off limits as is exercising outdoors during the ...

A 27-year-old has been left unable to drink chilled beverages or exercise outdoors in winter after developing a rare cold ...

Lawmakers took a step Wednesday to cap the out-of-pocket cost for epinephrine injectors and ensure Nebraska schools and licensed child care programs have policies to respond to allergic reactions.

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic reactions in patients who weigh between 15 and 30 kilograms, the company said on ...